9 Meters Biopharma, Inc.
NMTRQ
$0.00
$0.000.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -46.28M | -43.77M | -41.39M | -45.58M | -42.70M |
| Total Depreciation and Amortization | 8.20K | 8.50K | 8.90K | 8.60K | 8.00K |
| Total Amortization of Deferred Charges | 2.41M | 1.83M | 500.40K | 0.00 | 0.00 |
| Total Other Non-Cash Items | 4.56M | 4.02M | 4.15M | 6.63M | 5.29M |
| Change in Net Operating Assets | 2.06M | 661.50K | 1.26M | 5.26M | 4.40M |
| Cash from Operations | -37.24M | -37.24M | -35.48M | -33.68M | -33.00M |
| Capital Expenditure | 0.00 | -2.80K | -5.40K | -8.40K | -10.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | -2.42M | -2.42M |
| Cash from Investing | 0.00 | -2.80K | -5.40K | -2.43M | -2.43M |
| Total Debt Issued | 21.00M | 21.00M | 21.00M | -- | -- |
| Total Debt Repaid | -16.75M | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | 5.00M | -- | 1.36M | 1.79M | 37.08M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.63M | -1.09M | -1.09M | -250.00K | -2.90M |
| Cash from Financing | 7.63M | 19.91M | 21.27M | 1.54M | 34.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.62M | -17.33M | -14.21M | -34.57M | -1.25M |
